Professional Documents
Culture Documents
Dr. Muh. Nasrum Massi, Ph.D Bagian Mikrobiologi Fak. Kedokteran Unhas
Antimicrobial Agents
Microbiocidal kills, e.g. bacteriocidal Microbiostatic inhibits growth but does not kill, e.g. bacteriostatic Narrow spectrum drug specific for one genus, e.g. Mycobacterium, or one group of organisms, e.g. Gram negatives Broad spectrum good for all bacteria Selection of Drugs depends on: - microbial sensitivity - side effects - biotransformation will it remain active in the body? - distribution must reach correct site of infection
o most differ due to particular side groups which are added to enhance activity, e.g. Pen G only works with Gram positives but once you add the amino group (NH2) to make Ampicillin the drug can get past the bulky LPS on Gram negative cell surfaces and work for them too o many penicillin resistant bacteria exist, make -lactamase (penicillinase) which cleaves the lactam ring structure of these antibiotics, cephalosporins are still left intact b) Vancomycin blocks linkage of NAG and NAM of the PG o used for MRSA (methicillin resistant Staphylococcus aureus) c) Bacitracin same function as vancomycin, very toxic so used externally as an ointment, e.g. Polysporin
3. Membrane Inhibiters Polymyxin B o incorporates into the cell membrane and pokes holes causes cell lysis o very toxic targets our membranes too o used for antibiotic resistant bacteria , e.g. Pseudomonas aeruginosa 4. DNA Replication Inhibiters Quinilones Ciprofloxacin, Norfloxacin, Nalidixic Acid o binds DNA Gyrase and blocks unwinding of DNA o broad sprectrum 5. Sulfa Drugs (Sulfonamides) Para-amino benzoic acid (PABA) analogs Trimethoprim, Sulfamethoxazole PABA is the bacterial metabolic building block to make Folic Acid o Folic Acid is an essential metabolite o Drugs block folic acid production o We get folic acid from our diet and do not produce it like bacteria o Broad spectrum
6. Isoniazid (INH) o very narrow spectrum, only Mycobacterium species, e.g. Mycobacterium tuberculosis o blocks the synthesis of the unusual compounds found only in mycobacterial cell walls (mycolic acids)
Antifungal Agents
- some risk of toxicity as fungi are eucaryotes like us - most target fungal lipid production so tend to be quite specific for fungi 1. Polyenes o Amphoteracin B, Nystatin o Alter the permeability of fungal membranes by inserting into membranes and poking holes o Used topically for yeast infection, e.g. thrush, vaginitis 2. Imidazoles o Miconazole, Ketoconazole o Interfere with fungal sterol production o Side effects liver damage and liver is the site of our sterol production o Yeast infections 3. Griseofulvin o interferes with fungal cell division o taken orally but locates in the skin and nails o used for nail infections o must take for 6-8 months, or until infected nail grows out
Antiprotozoan Agents
- high toxicity problem - very few drugs, all highly specific for one type of protozoa 1. Quinine o Chloroquinine, Fluoroquinine o Antimalarial agent o Interferes with DNA replication of the malaria protozoa during a specific stage of its life cycle 2. Metronidazole (shelf name Flagyl) o inhibits metabolism of anaerobic organisms o used for certain protozoa (Giardia lamblia beaver fever), certain bacteria (Clostridium difficle), and yeast infections
Antiviral Agents
1. Nucleotide Analogs o block viral replication o many, e.g. Acyclovir Herpes infections; AZT targets Reverse Transcriptase of HIV 2. Interferons o just like our naturally produce compound o triggers cells to produce an enzyme that blocks viral replication o best for RNA viruses
INTRODUCTION
Antibiotic: chemical substance produced by mo (mainly fungi) low concentration: inhibit growth of other mo used to treat infectious disease Antimicrobials(AM): a substance that can prevent mo growth or can kill mo: Natural AM, synthetic or semisynthetic AM Chemotherapeuticals: chemicals used to prevent or treat disease. Antibiotic as chemotherapeutical can work as: Bacteriostatic and bactericidal
Prevent growth or disrupt pathogenic mo but cause no damage to host. Bactericidal > bacteriostatic. Does not result in bacterial resistance Effective to as much bacteria as possible Does not cause allergy or other side effects. Must be steadily active in plasma, exudate, and other body fluid. Soluble in water and stable.
Antibacterial spectra: Narrow spectra: sensitive to a small amount of bacteria. Broad spectra: sensitive to a large amount of bacteria.
Rational treatment: right target, right dose, right regiment and right method of drug administration For a rational antibiotic treatment, it is important to know: 1. Microbiology : the etiological agent of infection & still sensitive tests are needed 2. Clinical: infected tissue 3. Pharmacology: drug mechanism, toxic characteristic, side effects
D.
Antimicrobials that inhibit cell wall synthesis Antibiotics that inhibit cell membrane function Antimicrobials that inhibit DNA structure and function Antimicrobials that inhibit protein synthesis
Bacterial cell wall contain mucopeptides=peptidoglycan Gram positive bacteria: >> peptidoglycan in comparison to Gram negative bacteria Peptidoglycan: polysaccharide that is cross bound with polypetide. the cross binding is the result of transpeptidase reaction. Inhibiting substance to this enzyme inhibit cross binding formation inhibit cell wall synthesis.
-lactam antibiotic
A.
Penicillin
Synthetic penicillin : methicillin, nafcillin, and isozazolyl penicillin (cloxacillin, dicloxacillin, oxacillin) Penicillin with broad spectrum: aminopenicillin ( ampicillin, amoxycillin), carboxy-penicillin ( : cerbenicillin, ticarcillin), and piperacillin. Penicillin with broad spectrum could not stand penicillinase used together with antibiotics which inhibit laktamase, exp. asam clavulanic, sulbactam.
B. Cephalosporin Produced by Cephalosporin. Structure and mechanism is similar to penicillin, structural basis of synthetic cephalosporin Spectrum: broad. Toxicity : more toxic than penicillin subtly nephrotoxic.
Circulating Cephalosporin:
First generation cephalosporin : oral and injection cefazolin, cephalexin, dan cephalothin. Second generation cephalosporin: ke>an injection: cefamandole, cefaclor, cefoxitin, dan cefuroxime. Third generation cephalosporin: ke>an injection cefotaxime, dan ceftriaxone. Fourth generation cephalosporin: Ke>an injection.
Bacitracin: Produced by: Bacillus subtilis, Prevent peptidoglycan polymerization Bactericidal to Gram positive bacteria Nephrotoxic & autotoxic by parenteral administration > Used topically
Cell membrane functions as osmotic barrier to regulate diffusion of intracellular and extracellular fluid. Substance working on cell membrane is independent and starts soon after bacterial cell encounters the antibacterial agent This substance can hardly differentiate between microbial cell and host tissue cell toxic seldom used.
Polymyxin: produced by Bacillus polymyxa (A, B, C, D, and E.) only polymyxin B and polymyxin-E (colisin) are used Mechanism: forms bond with outer part of cell membrane cell structure & osmotic features change. Bactericidal mainly for: P. aeruginosa Not active against fungi.
. Polyenes: Microlide antibiotics selectively inhibit growth of microorganism with sterol containing membrane. Important in this group: antifungal amphotericin B & nystatin yeast, fungi, other eukaryotic cells Does not inhibit procaryotic bacteria that lack sterol in their membranes.
Nalidixic acid: first introduced from this group it was used for treatment without complication now replaced with new quinolones Norfloxacine & Ciprofloxacine Spectrum:belongs to enterococcus, streptococci, and Pseudomonas Ciprofloxacine is the most potential active for most part of gram negative and gram positive bacteria, used orally for respiratory tract infection and digestive tract infection
Metronindazole: for treatment of anaerobic infection and infection of several protozoans Not useful for facultative anaerobes and aerobes Synthetic as derivative of 5-nitromidazole Novobiocin: Produced by Streptomyces niveus, inhibit DNA multiplication Bactericide maily for Gram positive bacteria. Currently not used for treatment
2. Tetracyclines
Natural antibiotic produced by Streptomyces , (tetracycline and derivatives: chlortetracycline, oxytetracyclin. Synthetic: methacyclin doxycyclin, and minocyclin Bakteriostatic with broad spectrum. Effective for intracellular bacterial infection & alternative drug to penicillin. Tetracycline is not useful for treatment because it is not secreted by kidney. Tetracycline toxicity: GI & candida superinfection & other fungi Not allowed for children & pregnant woman
Chloramphenicol: first antimicrobia to be synthesized in laboratory. Broad spectrum, anaerobic bacteria included. First choice for treatment of tiphoid fever, and meningitis by N. meningitidis. Toxicity : can cause pansitopenia because of obstruction to haematopoetik system
The macrolides a (erythromycin, azitromycin): A special antibiotic containing lactone macrocyclic circle consists of 12-22 carbon atom binding to one or more sugars. Narrow spectrum & toxic to the heart. Antibiotic of this group: Erythromycin: the most important in macrolides. Mainly bacteriostatic, but bactericidal if applied in high concentration. First choice in treatment of Mycoplasma pneumoniae, L. pneumophila, diphteria, and pertussis. Also used as an alternetive to infection of strept. Group A and patients allergic to penicillin.
The linkomycines (lincomycin dan clindamycin). Second spectrum of this drug = erythromycin, although there is no chemical relationship. Both are active against strept. group A, & staph. Producing penicillinase. Clindamycin: lincomycin derivative absorbed better compared to lincomycin. Activity > to anaerobic bacterial infection mainly Bacteroides fragilis. Because of its spectrum, low toxicity, and clinical efficay is most suitable to replace penicillin.
Griseofulvin: specifically for treating fungi with chitinous cell wall Not useful for bacteria and fungi with cell walls composed of cellulose, exp. Yeasts.
Most of bacteria need folic acid self synthesized using PABA (para-amino-benzoic acid) as basic material. Antibiotic group that inhibit folic acid synthesis and interferes with purine and pyrimidine metabolism are antibiotics with similar structures to PABA, such that folic acid synthesis is disrupted because PABA is replaced by the antibiotic.
Sulphonamides: sulfadiazine, sulfafurazole, sulfamethoxazole, sulfoxazole, sulfamethoxazole Bacteriostatic with broad spectrum. Well reabsorbed in the intestine in adequate amount in the blood after preoral treatment.
Minor features of sulphonamides: Second administration could result in hypersensitivity reaction. High dosis administration: cause haemotological abnormality & crystal formation in genitourinary tract. Causes: an. Haemolitic because of its toxic effect to the liver. Toxic to kidney.
Trimetoprim: structure is similar to hydrofolic acid able to bind to dihydrofolate reductase enzyme needed for folat metabolism. Sulphamethoxazole-trimetoprim (cotrimoxazole): combination synergistic Frequently used for ISK and bacterial gastroenteritis.
Sulphones Sulphon derivative known as Dapsone: Treatment of infection by genus Mycob., commonly used for treating leprae. Toxic reaction in dapson administration: an. haemolytic, peripheral neuropathy, dermatitis, and eritema nodosum. P-Aminosalicylic acid (PAS). PAS activity is specifically against M. tbc Bacteriostatic: similar structure to PABA invivo could be inhibited by PABA.
Intrinsic resistance Related to bacterial structure: bacterial cell wall permeability. Bacterial natural immunity is carried by genes inside the chromosome. Exp. Immunity of P. aeroginosa to antibiotic. Resistance caused by mutation (Mutational resistance) Bacterial resistance is the result of chromosomal mutation bacteria previously sensitive to antimicrobial drug becomes resistant.
Mutations
Acquisition of resistance genes Bacteria resistance occur as the result of: - movement of plasmid carrying resistance gene ( R ) from other bacteria already resistant to a particular antibiotic. - formation of a new chromosomal gene.
Antimicrobial inactivation by enzym activity (Enzymatics inactivation) Resistance occur by change in bacterial cell wall permeability. Change in target molecule. Bacteria alters synthetic pathway utilized by antimicrobials. Antimicrobials is actively excreted out of bacterial cell. Occurrence of tolerance
Penicillin inactivation: hydrolysis of lactam ring by -lactamases. Aminoglycoside inactivation: alteration caused by acetyltransferase and phophorylase, nucleotidases activities unable to bind to ribosome. Chloramphenicol inactivation: chloramphinecol acetyltransferases have similar activity mechanism to aminoglycoside transferases.
Porin: outer membrane protein specific to Gram negative bacteria plays a role in entrance of hydrophilic antimicrobials. Porin mutation: antimicrobial transportation into the cell is hindered bacteria becomes resistent to multiple antimicrobials (multi-resistant) Lipopolysaccharide (LPS): inhibit the entrance of hydrophilic antimicrobials through the cell wall. Mutant containing small amount of polysaccharide capsules & small amount of LPS will be more permeable to many antimicrobials.
Membr. transport proteins. Mutation of membrane transport protein causes bacterial resistance to tetracycline as the result of reduction of transportation into the cell. Electron transport. The entrance of aminoglycosides into the cell is dependent on electron transport into oxygen. Thats why aminoglycoside is not effective against anaerobic bacteria & facultative bacteria in anaerobic environment, like abscess.
Antimicrobial targets could be: Cytoplasm: penicillin-binding protein (PBP), Membr. Cytoplasm: ribosom 30S atau ribosom 50S. Change in target molecule reduced bacterial affinity towards antibacterial. Example Change of 30S ribosome bacterial resistance to aminoglyside. Change of 50S ribosome bacterial resistance to macrolide Change of DNA gyrase: bacterial resistance to quinolone.
The formation of mutant enzyme change in synthetic pathway. Exp. Bacteria resistant to vancomycin produce an enzyme with low affinity to vancomycin.
F. Antimicrobials are actively excreted from the bacteria. Bacterial resistance to tetracycline is caused by the formation of a new transport protein which could actively excreted antimicrobials out of bacterial cell. G. Occurrence of tolerance With the lost of outer membrane permeability & autolytic enzyme inactivation, changes of bactericidal substance into bacteriostatic substance would occur.
Increase in strains resistant ( R) to antibody. Disease suffered by patients gets more severe. Increase in mortality. Increase in infection. Increase in treatment cost.
Diffusion Method: only to see resistance Diffusion Method is recommended by the National Committee of Clinical Laboratory Standard (NCCLS) United States.
Tube Dilution Method : to determine MIC & MBC MIC : minimum concentration of antibacterials which could still inhibit the growth of bacteria. MBC :minimum concentration of antibacterials which could still kill bacteria.